Medicine and Dentistry
Human Immunodeficiency Virus
100%
Patient
58%
Nephropathy
57%
Chronic Kidney Disease
45%
Glomerular Filtration Rate
41%
Kidney Function
35%
Tenofovir Disoproxil
34%
Tenofovir
22%
Creatinine
21%
Kidney Tubule Disorder
21%
Bone Density
20%
Bone
20%
Monotherapy
17%
Clinical Trial
14%
Inpatient
14%
End Stage Renal Disease
14%
Mortality
12%
Kidney
12%
Emtricitabine
11%
Secretion (Process)
10%
Antiretroviral Therapy
10%
Association
10%
HIV-associated Nephropathy
10%
Age
10%
Albumin
9%
Disease Exacerbation
9%
Excretion
9%
Proteinase Inhibitor
9%
Nonnucleoside Reverse Transcriptase Inhibitor
9%
Proteinuria
8%
Protein
8%
Encephalitis
8%
Efavirenz
8%
Aging
8%
Adult
8%
Vitamin D
8%
Experience
8%
Renal Failure
8%
Sickle Cell Trait
8%
Antigen Antibody Complex
8%
Predictor
8%
Diet
8%
Randomized Controlled Trial
8%
Genetic Variability
8%
Kidney Transplantation
8%
Woman
8%
Insulin Resistance
8%
Lamivudine
8%
Cohort Effect
8%
Odds Ratio
8%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
37%
Chronic Kidney Failure
27%
Tenofovir Disoproxil
21%
Kidney Tubule Disorder
20%
Creatinine
20%
Tenofovir Alafenamide
17%
Tenofovir
12%
End Stage Renal Disease
11%
Controlled Clinical Trial
8%
Albumin
8%
Protein
8%
Kidney Disease
8%
Epidemiology
8%
Deterioration
7%
Cohort Study
7%
Proteinuria
6%
Prevalence
5%
Biological Marker
5%